The present invention relates to anti-FGFR2 and FGFR4 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
申请公布号
CA2904090(A1)
申请公布日期
2014.10.02
申请号
CA20142904090
申请日期
2014.03.13
申请人
NOVARTIS AG
发明人
ETTENBERG, SETH;HAUBST, NICOLE;HU, TIANCEN;JENKINS, DAVID;TOKSOZ, ENGIN;MOSHER, REBECCA;MEYER, MATTHEW JOHN;PETROPOULOS, KONSTANTIN;BATT, DAVID BRYANT
